Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-175.31%
operating margin TTM
-133.21%
revenue TTM
107.38 Million
revenue per share TTM
0.85$
valuation ratios | |
|---|---|
| pe ratio | -4.16 |
| peg ratio | -0.24 |
| price to book ratio | -3.19 |
| price to sales ratio | 6.17 |
| enterprise value multiple | -3.04 |
| price fair value | -3.19 |
profitability ratios | |
|---|---|
| gross profit margin | 90.57% |
| operating profit margin | -133.21% |
| pretax profit margin | -175.5% |
| net profit margin | -175.31% |
| return on assets | -44.14% |
| return on equity | 66.23% |
| return on capital employed | -42.84% |
liquidity ratios | |
|---|---|
| current ratio | 4.37 |
| quick ratio | 4.31 |
| cash ratio | 3.72 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 199.00 |
| operating cycle | 329.63 |
| days of payables outstanding | 436.39 |
| cash conversion cycle | -106.76 |
| receivables turnover | 2.79 |
| payables turnover | 0.84 |
| inventory turnover | 1.83 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.36 |
| debt equity ratio | -2.36 |
| long term debt to capitalization | 1.74 |
| total debt to capitalization | 1.73 |
| interest coverage | -2.10 |
| cash flow to debt ratio | -0.32 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.94 |
| cash per share | 1.74 |
| operating cash flow per share | -0.94 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.32 |
| short term coverage ratios | -47.06 |
| capital expenditure coverage ratio | -508.25 |
Frequently Asked Questions
When was the last time ADC Therapeutics S.A. (NYSE:ADCT) reported earnings?
ADC Therapeutics S.A. (ADCT) published its most recent earnings results on 10-11-2025.
What is ADC Therapeutics S.A.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADC Therapeutics S.A. (NYSE:ADCT)'s trailing twelve months ROE is 66.23%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADC Therapeutics S.A. (ADCT) currently has a ROA of -44.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADCT's net profit margin stand at?
ADCT reported a profit margin of -175.31% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.37 in the most recent quarter. The quick ratio stood at 4.31, with a Debt/Eq ratio of -2.36.